IL17A and experimental autoimmune encephalomyelitis: TRAF3 suppresses the development of experimental autoimmune encephalomyelitis (EAE) and IL-17 mediated EAE in part by its role as a negative regulator of the IL-17 induced inflammation and autoimmunity.